{"id":"https://openalex.org/W2081666142","doi":"https://doi.org/10.1007/s10147-015-0825-4","title":"Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?","display_name":"Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?","publication_year":2015,"publication_date":"2015-04-03","ids":{"openalex":"https://openalex.org/W2081666142","doi":"https://doi.org/10.1007/s10147-015-0825-4","mag":"2081666142","pmid":"https://pubmed.ncbi.nlm.nih.gov/25837976"},"language":"en","primary_location":{"id":"doi:10.1007/s10147-015-0825-4","doi":"https://doi.org/10.1007/s10147-015-0825-4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10147-015-0825-4","pdf_url":null,"source":{"id":"https://openalex.org/S103913600","display_name":"International Journal of Clinical Oncology","issn_l":"1341-9625","issn":["1341-9625","1437-7772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037467101","display_name":"Hideki Maeda","orcid":"https://orcid.org/0000-0002-0117-3961","observed_orcids":["https://orcid.org/0000-0002-0117-3961"]},"institutions":[{"id":"https://openalex.org/I142395110","display_name":"Astellas Pharma (Japan)","ror":"https://ror.org/01cjash87","country_code":"JP","type":"company","lineage":["https://openalex.org/I142395110"]},{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hideki Maeda","raw_affiliation_strings":["Division of Drug Development and Regulatory Science, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan. hideki.maeda@astellas.com","Oncology, Clinical Development Department, Global Development, Astellas Pharma Inc., 2-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, 103-8411, Japan. hideki.maeda@astellas.com","Astellas Pharma Inc","Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Drug Development and Regulatory Science, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan. hideki.maeda@astellas.com","institution_ids":["https://openalex.org/I203951103"]},{"raw_affiliation_string":"Oncology, Clinical Development Department, Global Development, Astellas Pharma Inc., 2-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, 103-8411, Japan. hideki.maeda@astellas.com","institution_ids":["https://openalex.org/I142395110"]},{"raw_affiliation_string":"Astellas Pharma Inc","institution_ids":[]},{"raw_affiliation_string":"Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103712061","display_name":"Tatsuo Kurokawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsuo Kurokawa","raw_affiliation_strings":["Division of Drug Development and Regulatory Science, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan","Keio Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Drug Development and Regulatory Science, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan","institution_ids":["https://openalex.org/I203951103"]},{"raw_affiliation_string":"Keio Univ","institution_ids":["https://openalex.org/I203951103"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5037467101"],"corresponding_institution_ids":["https://openalex.org/I142395110","https://openalex.org/I203951103"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":7.2387,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.9661704,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"20","issue":"6","first_page":"1072","last_page":"1080"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-lag","display_name":"drug lag","score":0.9959999918937683},{"id":"https://openalex.org/keywords/oncology-drugs","display_name":"oncology drugs","score":0.9039999842643738},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.699999988079071},{"id":"https://openalex.org/keywords/us-japan-comparison","display_name":"Japan-US comparison","score":0.6240000128746033},{"id":"https://openalex.org/keywords/clinical-drug-development","display_name":"clinical development","score":0.5450000166893005},{"id":"https://openalex.org/keywords/molecularly-targeted-agents","display_name":"molecularly targeted agents","score":0.8109999895095825},{"id":"https://openalex.org/keywords/global-clinical-trials","display_name":"global clinical trials","score":0.878000020980835},{"id":"https://openalex.org/keywords/bridging-strategy","display_name":"bridging strategy","score":0.8849999904632568},{"id":"https://openalex.org/keywords/regulatory-approval-time","display_name":"regulatory approval time","score":0.35600000619888306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8104573488235474},{"id":"https://openalex.org/C2780140570","wikidata":"https://www.wikidata.org/wiki/Q3545481","display_name":"Surgical oncology","level":2,"score":0.7000007629394531},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.6053026914596558},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.600206196308136},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.543734073638916},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5352855920791626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5236266255378723},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4988248348236084},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.4206995368003845},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2805364727973938},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2105238437652588}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10147-015-0825-4","doi":"https://doi.org/10.1007/s10147-015-0825-4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10147-015-0825-4","pdf_url":null,"source":{"id":"https://openalex.org/S103913600","display_name":"International Journal of Clinical Oncology","issn_l":"1341-9625","issn":["1341-9625","1437-7772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:25837976","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25837976","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1854660933","https://openalex.org/W1910685887","https://openalex.org/W1964888871","https://openalex.org/W1980801068","https://openalex.org/W1986881091","https://openalex.org/W2003277755","https://openalex.org/W2005763656","https://openalex.org/W2010072448","https://openalex.org/W2030234436","https://openalex.org/W2030837172","https://openalex.org/W2040940457","https://openalex.org/W2045148891","https://openalex.org/W2051737185","https://openalex.org/W2060207975","https://openalex.org/W2062301656","https://openalex.org/W2063118124","https://openalex.org/W2063500683","https://openalex.org/W2072010297","https://openalex.org/W2080617972","https://openalex.org/W2090884751","https://openalex.org/W2103627553","https://openalex.org/W2114136779","https://openalex.org/W2123762592","https://openalex.org/W2126035587","https://openalex.org/W2130229071","https://openalex.org/W2139545591","https://openalex.org/W2142157466","https://openalex.org/W4285719527","https://openalex.org/W4398792087"],"related_works":["https://openalex.org/W4360944179","https://openalex.org/W4385716840","https://openalex.org/W4387472185","https://openalex.org/W2063500683","https://openalex.org/W1854660933","https://openalex.org/W4286265347","https://openalex.org/W7095908560","https://openalex.org/W4414750471","https://openalex.org/W3107069451","https://openalex.org/W2015727799"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}